Company / Depreciation & Amortization
Zimmer Biomet Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$1.1B
FY2025
5-year range
$926.4M / $1.1B
FY2021-FY2025
Trend
+9.8%
vs FY2024
Sector context
#12 of 142
Health Care
What the data says
Among 142 Health Care companies, Zimmer Biomet is in the bottom 8% for depreciation & amortization. Depreciation & Amortization has increased for 3 consecutive years, from $926M in FY2022 to $1.1B in FY2025.
Based on SEC 10-K filings.
$1.1B in FY2025 with a 5-year CAGR of +4.0%. Top quartile in the Health Care sector.
Increased from $952M to $1.1B over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +5.7%
- 5-Year CAGR
- +4.0%
- 10-Year CAGR
- -
Sector benchmark
+214.8% above sector average
Key checks
Key Insights
- Zimmer Biomet's depreciation & amortization has grown for 3 consecutive years.
- 5-year CAGR of +4.0%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 9.8% year-over-year.
- Ranks #12 out of 142 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1B | +9.8% |
| FY2024 | $996.3M | +4.7% |
| FY2023 | $951.7M | +2.7% |
| FY2022 | $926.4M | -1.2% |
| FY2021 | $937.7M | +4.4% |
| FY2020 | $898.4M | -15.5% |
| FY2019 | $1.1B | +2.3% |
| FY2018 | $1.0B | -2.2% |
| FY2017 | $1.1B | +182.8% |
| FY2016 | $375.8M | -47.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026